Page 293 - E-book การประชุมวิชาการครั้งที่ 36
P. 293

เอกสารอ้างอิง
                         1.  Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta

                  accreta. Am J Obstet Gynecol. 2010;203:430-9.

                         2.  Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on

                  placenta accreta spectrum disorders: epidemiology. Int J Gynecol Obstet. 2018;140:265-73.

                         3.  Fitzpatrick K, Sellers S, Spark P, Kurinczuk J, Brocklehurst P, Knight M. The management

                  and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive

                  study. Int J Obstet Gynaecol. 2014;121:62-71.

                         4.  Irving C, Hertig AT. A study of placenta accreta. Surg Gynecol Obstet. 1937;64:178-200.
                         5.  Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic

                  uterine disease. Placenta. 2012;33:244-51.

                         6.  Randall S, Buckley CH, Fox H. Placentation in the Fallopian Tube. Int J Gynecol Pathol.

                  1987;3:132-9.

                         7.  Godyn JJ, Hazra A, Gulli VM. Subperitoneal placenta accreta succenturiate in the case

                  of  a  successful near-term  extrauterine  abdominal  pregnancy.  Hum  Pathol.  2005;36(8):922–6.

                  doi:10.1016/j.humpath.2005.05.020
                         8.  Irving  C,  Hervig  AT.  A  Study  of  Placenta  Accreta.  Surg  Gynecol  Obstet.  64th  ed.

                  1937:178-200.

                         9.  Badr DA, Al Hassan J, Salem Wehbe G, Ramadan MK. Uterine body placenta accreta

                  spectrum: A detailed literature review. Placenta. 2020;95:44-52.

                         10.  Modest AM, Toth TL, Johnson KM, Shainker SA. Placenta Accreta Spectrum: in Vitro

                  Fertilization and Non-In Vitro Fertilization and Placenta Accreta Spectrum in a Massachusetts

                  Cohort. Am J Perinatol. 2020;5:s-0040-1713887.

                         11.  Salmanian B, Fox KA, Arian SE, et al. In vitro fertilization as an independent risk factor

                  for placenta accreta spectrum. Am J Obstet Gynecol. 2020;S0002937820305111.
                         12.  Jauniaux E, Collins S, Burton GJ. The placenta accreta spectrum: Pathophysiology and

                  evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2017; pii: S0002-

                  9378(17)30731-7. https://doi.org/10.1016/j.ajog.2017.05.067.[Epub ahead of print].




                  Clinical diagnosis of abnormal placentation                                               277
   288   289   290   291   292   293   294   295   296   297   298